diethyl acetamidomalonic acid: RN given refers to unlabeled parent cpd
ID Source | ID |
---|---|
PubMed CID | 14041 |
CHEMBL ID | 3278808 |
SCHEMBL ID | 81193 |
SCHEMBL ID | 13410508 |
MeSH ID | M0097698 |
Synonym |
---|
4vdx81e00w , |
propanedioic acid, 2-(acetylamino)-, 1,3-diethyl ester |
unii-4vdx81e00w |
4-04-00-02993 (beilstein handbook reference) |
diethylester kyseliny acetylaminomalonove |
nsc-7645 |
diethyl acetylaminomalonate |
acetamidomalonic acid diethyl ester |
(acetylamino)propanedioic acid diethyl ester |
wln: 2ovyvo2&mv1 |
nsc7645 |
diethyl 2-acetamidomalonate |
diethyl acetaminomalonate |
1068-90-2 |
diethyl acetamidomalonate |
brn 0783883 |
ai3-52334 |
einecs 213-952-9 |
nsc 7645 |
diethyl acetamidomalonic acid |
malonic acid, acetamido-, diethyl ester |
diethylester kyseliny acetylaminomalonove [czech] |
hsdb 2664 |
inchi=1/c9h15no5/c1-4-14-8(12)7(10-6(3)11)9(13)15-5-2/h7h,4-5h2,1-3h3,(h,10,11 |
propanedioic acid, (acetylamino)-, diethyl ester |
CBDIVE_002969 |
diethyl 2-acetamidopropanedioate |
acetamidomalonic acid, diethyl ester |
SR-01000635034-1 |
diethyl acetamidomalonate, 98% |
D-2400 |
A0015 |
diethyl (acetylamino)propanedioate |
STK802461 |
AKOS000120193 |
diethyl (acetylamino)malonate |
2-acetylaminomalonic acid diethyl ester |
BBL011570 |
diethyl 2-acetylaminomalonate |
1,3-diethyl 2-acetamidopropanedioate |
acetaminomalonic acid diethyl ester |
CCG-45254 |
GEO-01032 |
BP-12339 |
FT-0621728 |
AM20080015 |
F3098-5039 |
acetamidomalonic acid diethyl ester [hsdb] |
diethyl (n-acetylamino)malonate |
CHEMBL3278808 |
AB00274777-04 |
SCHEMBL81193 |
DTXSID6061446 |
2-acetylamino-malonic acid diethyl ester |
diethyl acetamido malonate |
2-acetylaminopropanedioic acid diethyl ester |
acetamido diethyl malonate |
diethyl alpha-(acetamido)-malonate |
diethyl-2-acetamidomalonate |
diethyl 2-acetylamino-malonate |
diethyl n-acetylaminomalonate |
diethyl 2-(acetylamino)malonate |
diethyl acetamido-malonate |
diethyl(n-acetylamino)malonate |
SCHEMBL13410508 |
2-(acetylamino)propanedioic acid diethyl ester |
diethyl a-(acetylamino)malonate |
diethyl 2-(acetylamino)malonate # |
(acetylamino)malonic acid diethyl ester |
mfcd00009146 |
SY001093 |
FT-0773409 |
EN300-16887 |
BCP26461 |
diethyl2-acetamidomalonate |
11G-367S |
Q27260567 |
NCGC00328362-01 |
CS-0011321 |
HY-I1162 |
Z56812731 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1149944 | Binding affinity to chymotrypsin (unknown origin) | 1977 | Journal of medicinal chemistry, Nov, Volume: 20, Issue:11 | Quantitative structure-activity relationship of chymotrypsin-ligand interactions. |
AID1149943 | Binding affinity to chymotrypsin (unknown origin) assessed as hydrolysis | 1977 | Journal of medicinal chemistry, Nov, Volume: 20, Issue:11 | Quantitative structure-activity relationship of chymotrypsin-ligand interactions. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.78) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |